Kohlberg to acquire pharma company Worldwide Clinical Trials
When the deal closes, Worldwide's current backer TJC will retain a minority equity stake.
When the deal closes, Worldwide's current backer TJC will retain a minority equity stake.
Copyright PEI Media
Not for publication, email or dissemination